Sign In to Follow Application
View All Documents & Correspondence

Composition For Cardiovascular Health

Abstract: Cholesterol is one of the biomarkers that is associated with cardiovascular diseases and hence an important biological target for management of metabolic disorders. The present disclosure provides a composition comprising pomegranate extract and bilberry extract, which at particular w/w ratios, inhibits intracellular cholesterol production.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
23 December 2016
Publication Number
26/2018
Publication Type
INA
Invention Field
BIOTECHNOLOGY
Status
Email
iprdel@lakshmisri.com
Parent Application

Applicants

ITC LIMITED
ITC LIFE SCIENCES & TECHNOLOGY CENTRE #3. 1st Main, Peenya Industrial Area, Phase-1, Bangalore 560 058, India

Inventors

1. KUDTARKAR, Kavita Gopalkrishna
ITC LIFE SCIENCES & TECHNOLOGY CENTRE #3. 1st Main, Peenya Industrial Area, Phase-1, Bangalore 560 058, India
2. SHETTY, Shilpa
ITC LIFE SCIENCES & TECHNOLOGY CENTRE #3. 1st Main, Peenya Industrial Area, Phase-1, Bangalore 560 058, India
3. KS, Nandakumar
ITC LIFE SCIENCES & TECHNOLOGY CENTRE #3. 1st Main, Peenya Industrial Area, Phase-1, Bangalore 560 058, India
4. CHITTUR, Lakshmanan Chandrasekharan
ITC LIFE SCIENCES & TECHNOLOGY CENTRE #3. 1st Main, Peenya Industrial Area, Phase-1, Bangalore 560 058, India

Specification

Claims:1. A composition comprising:
a. pomegranate extract; and
b. bilberry extract,
wherein pomegranate extract to bilberry extract w/w ratio in said composition is in the range of 1:0.25-1:1.5.
2. The composition as claimed in claim 1, wherein said pomegranate extract comprises polyphenols not less than 13%.
3. The composition as claimed in claim 1, wherein said bilberry extract comprises anthocyanidins not less than 25%.
4. The composition as claimed in claim 1, wherein pomegranate extract to bilberry extract w/w ratio in said composition is 1:0.25.
5. The composition as claimed in claim 1, wherein pomegranate extract to bilberry extract w/w ratio in said composition is 1:0.6.
6. The composition as claimed in claim 1, wherein pomegranate extract to bilberry extract w/w ratio in said composition is 1:1.
7. The composition as claimed in claim 1, wherein pomegranate extract to bilberry extract w/w ratio in said composition is 1:1.5.
8. The composition as claimed in claim 1, further comprising suitable carriers, diluents, and excipients.
9. A method of preparing a composition as claimed in claim 1, said method comprising:
a. obtaining pomegranate extract;
b. obtaining bilberry extract; and
c. contacting said extracts to obtain a composition.
10. A method of preparing a composition as claimed in claim 8, said method comprising:
a. obtaining pomegranate extract;
b. obtaining bilberry extract;
c. obtaining suitable carriers, diluents, and excipients; and
d. contacting said extracts and suitable carriers, diluents, and excipients to obtain a composition.
11. A method of inhibiting intracellular cholesterol levels, said method comprising:
a. obtaining a composition as claimed in claim 1 or claim 8; and
b. contacting said composition with a cell capable of producing cholesterol,
wherein said method inhibits intracellular cholesterol levels.
, Description:As Attached

Documents

Application Documents

# Name Date
1 Drawing_As Filed_22-12-2016.pdf 2016-12-22
2 Form5_As Filed_23-12-2016.pdf 2016-12-23
3 Form3_As Filed_23-12-2016.pdf 2016-12-23
4 Form2 Title Page_Complete_23-12-2016.pdf 2016-12-23
5 Description Complete_As Filed_23-12-2016.pdf 2016-12-23
6 Claims_As Filed_23-12-2016.pdf 2016-12-23
7 Abstract_As Filed_23-12-2016.pdf 2016-12-23
8 Other Patent Document [16-02-2017(online)].pdf 2017-02-16
9 Form 26 [16-02-2017(online)].pdf 2017-02-16
10 Correspondence by Agent_Power of Attorney_22-02-2017.pdf 2017-02-22